Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.58 |
| ▸ | THRA | P10827 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4820127 | 0.94 | ALOX15 (0.61) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| Formaldehyde SCHEMBL30592324 | 0.94 | ALOX15 (0.61) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| Chloroacetic Acid SCHEMBL7821121 | 0.92 | ALOX15 (0.59) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL339492 | 0.91 | ALOX15 (0.81) | ALOX15ALDH1A1FFAR1SMN1; SMN2PTPN7 | |
| SCHEMBL1550206 | 0.90 | FFAR1 (0.77) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL11261731 | 0.90 | ESR1 (0.60) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL13616217 | 0.89 | PPARD (0.67) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL9544330 | 0.89 | ALOX15 (0.55) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL31742271 | 0.89 | ALOX15 (0.55) | ALOX15ALDH1A1FFAR1SMN1; SMN2CYP19A1 | |
| SCHEMBL6001984 | 0.87 | ALDH1A1 (0.86) | ALOX15ALDH1A1SMN1; SMN2CYP19A1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118531038-A | Engineering strain transformation method for high-yield penicillin V and reduction of 4-hydroxy penicillin V impurities, engineering bacteria and application | 浙江工业大学 | 2024-08-23 | — | — | CN | claimed |
| CN-117757009-A | Preparation method of high-temperature-resistant high-efficiency sulfonated phenolic resin | 荆州市学成实业有限公司 | 2024-03-26 | — | — | CN | claimed |
| EP-2992041-B1 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS | VIRDIA INC (US) | 2020-01-08 | — | — | EP | claimed |
| EP-2991998-B1 | METHODS FOR PREPARING THERMALLY STABLE LIGNIN FRACTIONS | VIRDIA INC (US) | 2019-08-14 | — | — | EP | claimed |
| US-10138332-B2 | Methods for treating lignocellulosic materials | VIRDIA, INC. (US) | 2018-11-27 | — | — | US | claimed |
| US-20170313826-A1 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS | STORA ENSO OYJ (FI) | 2017-11-02 | — | — | US | claimed |
| US-9683005-B2 | Methods for preparing thermally stable lignin fractions | VIRDIA, INC. (US) | 2017-06-20 | — | — | US | claimed |
| US-9657146-B2 | Methods for treating lignocellulosic materials | VIRDIA, INC. (US) | 2017-05-23 | — | — | US | claimed |
| US-20160130408-A1 | METHODS FOR TREATING LIGNOCELLULOSIC MATERIALS | STORA ENSO OYJ (FI) | 2016-05-12 | — | — | US | claimed |
| US-20160102113-A1 | METHODS FOR PREPARING THERMALLY STABLE LIGNIN FRACTIONS | VIRDIA, INC. (US) | 2016-04-14 | — | — | US | claimed |
| WO-1995034675-A1 | IMPROVED ACYLATION METHOD FOR PENICILLINS AND CEPHALOSPORINS | GIST-BROCADES B.V. (NL) | 1995-12-21 | — | — | WO | claimed |
| EP-0374184-B1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE MEDICINE (US) | 1994-01-12 | — | — | EP | claimed |
| US-5216024-A | Compounds such as methyl p-hydroxypenyllactate, derivatives | BAYLOR COLLEGE OF MEDICINE (US) | 1993-06-01 | — | — | US | claimed |
| EP-0374184-A1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES. | BAYLOR COLLEGE MEDICINE (US) | 1990-06-27 | — | — | EP | claimed |
| WO-1989000849-A1 | CELL GROWTH INHIBITORS AND METHODS OF TREATING CANCER AND CELL PROLIFERATIVE DISEASES | BAYLOR COLLEGE OF MEDICINE (US) | 1989-02-09 | — | — | WO | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |